The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy
Open accessAbstract
ACE2, initially cloned from a human heart, is a recently described homologue of angiotensin-converting enzyme (ACE) but contains only a single enzymatic site that catalyzes the cleavage of angiotensin I to angiotensin 1–9 [Ang(1–9)] and is not inhibited by classic ACE inhibitors. It also converts angiotensin II to Ang(1–7). Although the role of ACE2 in the regulation of the renin-angiotensin system is not known, the renin-angiotensin system has been implicated in the pathogenesis of diabetic complications and in particular in diabetic nephropathy. Therefore, the aim of this study was to assess the possible involvement of this new enzyme in the kidney from diabetic Sprague-Dawley rats to compare and contrast it to ACE. ACE2 and ACE gene and protein expression were measured in the kidney after 24 weeks of streptozocin diabetes. ACE2 and ACE mRNA levels were decreased in diabetic renal tubules by ≈50% and were not influenced by ACE inhibitor treatment with ramipril. By immunostaining, both ACE2 and ACE protein were localized predominantly to renal tubules. In the diabetic kidney, there was reduced ACE2 protein expression that was prevented by ACE inhibitor therapy. The identification of ACE2 in the kidney, its modulation in diabetes, and the recent description that this enzyme plays a biological role in the generation and degradation of various angiotensin peptides provides a rationale to further explore the role of this enzyme in various pathophysiological states including diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Soulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1328 · Cited by 447
Self-citationAnderson, S., Jung, F. F., & Ingelfinger, J. R. (1993) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1993.265.4.f477 · Cited by 307
Short and long term effects of antihypertensive therapy in the diabetic rat
Anderson, S., Rennke, H. G., Garcia, D. L., Brenner, B. M., Riley, S. L., & Sandstrom, D. J. (1989) · Kidney International · doi:10.1038/ki.1989.227 · Cited by 306
Candido, R., Jandeleit-Dahm, K. A., Cao, Z., Nesteroff, S. P., Burns, W. C., Twigg, S. M., Dilley, R. J., Cooper, M. E., & Allen, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000021122.63813.32 · Cited by 261
Self-citationCooper, M. E., Boner, G., Cao, Z., Kawachi, H., Bonnet, F., & Allen, T. J. (2001) · Diabetologia · doi:10.1007/s001250100546 · Cited by 249
Self-citationThe role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
Wolf, G., & Ziyadeh, F. N. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90023-8 · Cited by 236
Vascular gp91 phox : Beyond the Endothelium
Pagano, P. J. (2000) · Circulation Research · doi:10.1161/01.res.87.1.1 · Cited by 229
Conversion of angiotensin I to angiotensin II
Erdös, E. G. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90889-5 · Cited by 215
Gilbert, R. E., Cox, A., Wu, L. L., Allen, T. J., Hulthen, U. L., Jerums, G., & Cooper, M. E. (1998) · Diabetes · doi:10.2337/diabetes.47.3.414 · Cited by 203
Self-citationAllen, T. J., Cao, Z., Youssef, S., Hulthén, U. L., & Cooper, M. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1612 · Cited by 135
Self-citationEarly diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat
Zimpelmann, J., Kumar, D., Levine, D. Z., Wehbi, G. J., Imig, J. D., Navar, L. G., & Burns, K. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00416.x · Cited by 133
Pathological Expression of Renin and Angiotensin II in the Renal Tubule after Subtotal Nephrectomy
Gilbert, R. E., Wu, L. L., Kelly, D. J., Cox, A. J., Wilkinson‐Berka, J. L., Johnston, C. I., & Cooper, M. E. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65139-5 · Cited by 131
Self-citationCharacterization of Angiotensin-(1-7) in the Urine of Normal and Essential Hypertensive Subjects
Ferrario, C. M. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00400-7 · Cited by 114
Angiotensin 1–9 and 1–7 release in human heart role of cathepsin, A
Jackman, H. L., Massad, M. G., Sekosan, M., Tan, F., Brovkovych, V., Marcic, B. M., & Erdös, E. G. (2002) · Hypertension · doi:10.1161/01.hyp.0000017283.67962.02 · Cited by 110
Kelly, D. J., Skinner, S. L., Gilbert, R. E., Cox, A. J., Cooper, M. E., & Wilkinson‐Berka, J. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00038.x · Cited by 103
Self-citationEarly streptozotocin-diabetes mellitus downregulates rat kidney AT2receptors
Wehbi, G. J., Zimpelmann, J., Carey, R. M., Levine, D. Z., & Burns, K. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f254 · Cited by 82
Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
Johnston, C. I., Fabris, B., & Jandeleit, K. (1993) · PubMed · Cited by 55
Self-citation
Cited by
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Kobori, H., Nangaku, M., Navar, L. G., & Nishiyama, A. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.3 · Cited by 1,237
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Metadata
- Authors
- Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W. C., Burrell, L. M., Risvanis, J., & Cooper, M. E.
- Venue
- Hypertension
- Published
- 2003-03
- Volume
- 41
- Issue
- 3
- Pages
- 392-397
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2060204625
- Cited by
- 350
- References
- 26
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.